On Demand: USP800 and Hazardous Drug Decontamination: From Theory to Practicality
Mar 3, 2022
Decontamination of hazardous drugs such as chemotherapy agents from surfaces in compounding areas is essential to reduce the risk of cross-contamination and occupational exposure. In sterile compounding, effective disinfection of microbial contamination also is required. The guidance in USP <800> provides a framework for complying with a mixture of “do's” and “don'ts”. However, there are several aspects of the guidance that still require additional considerations to implement best practices to reduce risk.
This fast-paced webinar aired Tuesday, February 22 and covered several products and processes to reduce hazardous drug residues from receipt to administration. It included comparisons among different decontamination agents and procedures and how to use the results of wipe sampling to gauge performance. The presentation covered a combination of scientific background and rationale with live demonstrations of key processes related to decontamination and tips, tricks, and caveats for sampling hazardous drug residues.
Click here to watch this informative webinar.